Korean biotechnology companies need differentiated strategies

Published: 2017-06-30 15:51:28

Updated: 2017-06-30 15:51:28

What are essential conditions for Korean biopharmaceutical companies to grow ahead of the Fourth Industrial Revolution?

Global experts chose governmental innovation and executive ability as the condition, stressing differentiated strategies. They also warned them not to be trapped in the Korean market as well.

At the ‘2917 Global Bio Conference’ on the 28^th, 3 lecturers – Michael Goettler, Gl...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.